Bicara Therapeutics Inc. (BCAX) Net income 2023–2025
Bicara Therapeutics Inc. (BCAX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$137.9MFY2025 · since FY2023: -$52.0M → -$137.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$137.9M | -102.9% |
| FY2024 | -$68.0M | -30.8% |
| FY2023 | -$52.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCAX financial trends
BCAX RevenueBCAX Net marginBCAX Gross profitBCAX Gross marginBCAX Operating incomeBCAX Operating marginBCAX Operating cash flowBCAX Free cash flowBCAX Capital expendituresBCAX Return on equityBCAX Stock buybacksBCAX Dividends paidBCAX Total assetsBCAX Total liabilitiesBCAX Shareholders’ equityBCAX overview →